ARTICLE | Company News
Biocartis sales and marketing update
September 22, 2014 7:00 AM UTC
Biocartis launched its Idylla molecular diagnostics platform and Idylla BRAF Mutation Test in countries that accept CE Mark. Idylla is an automated, real-time PCR-based molecular diagnostics system t...